Copyright
©The Author(s) 2016.
World J Gastroenterol. Jun 7, 2016; 22(21): 5104-5113
Published online Jun 7, 2016. doi: 10.3748/wjg.v22.i21.5104
Published online Jun 7, 2016. doi: 10.3748/wjg.v22.i21.5104
Figure 5 Changes in hepatic venous pressure gradient levels at day 0 and 7.
Data are expressed as median (range in parenthesis). A: Overall patients (n = 19); B: Patients (n = 7) with low HVPG (≤ 190 mmH2O); C: Patients (n = 12) with high HVPG (> 190 mmH2O). There was not significant difference in any groups, indicating that tolvaptan had little impact on HVPG. HVPG: Hepatic venous pressure gradient.
- Citation: Nakagawa A, Atsukawa M, Tsubota A, Kondo C, Okubo T, Arai T, Itokawa N, Narahara Y, Iwakiri K. Usefulness of portal vein pressure for predicting the effects of tolvaptan in cirrhotic patients. World J Gastroenterol 2016; 22(21): 5104-5113
- URL: https://www.wjgnet.com/1007-9327/full/v22/i21/5104.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i21.5104